Clinical Trial Update: Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia [Phase 3]

View source ↗

Summary

Phase 3 trial update on the clinical usability of intranasal glucagon for treating hypoglycemia in diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypoglycemia

Drugs mentioned

• intranasal glucagon (glucagon)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hypoglycemia, Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2019-10-15